Apr 27, 2026 08:30AM
Dec 16, 2025 08:30AM
Sep 30, 2025 08:30AM
Dec 7, 2023 04:00PM
Nov 3, 2023 04:02PM
Nov 3, 2023 04:02PM
May 24, 2023 05:06PM Cytodyn Inc. (CYDY) Announces President Takes Medical Leave of Absence
May 24, 2023 05:05PM
Nov 22, 2022 08:30AM
Oct 31, 2022 04:43AM
Oct 28, 2022 05:15PM
Jul 13, 2022 08:30AM
Jul 11, 2022 08:30AM
May 23, 2022 08:31AM Cytodyn Inc. (CYDY) Resolves Legal Dispute with Ex Chief Medical Officer
May 23, 2022 08:30AM
May 13, 2022 08:00AM
Apr 12, 2022 08:30AM
Mar 30, 2022 05:00PM
Jan 25, 2022 06:06PM
Jan 13, 2022 09:00AM
Jan 11, 2022 04:35PM CytoDyn to Hold Webcast and Live Q/A on January 13
Jan 10, 2022 09:00AM
Jan 10, 2022 08:00AM
Jan 5, 2022 09:26AM
Dec 22, 2021 08:39AM
Dec 21, 2021 08:56AM
Dec 13, 2021 08:00AM
Dec 10, 2021 03:59PM CytoDyn to Hold Webcast and Live Q/A on December 14
Dec 9, 2021 08:56AM
Dec 9, 2021 08:26AM
Dec 8, 2021 08:44AM
Dec 1, 2021 08:00AM
Nov 29, 2021 04:27PM
Nov 24, 2021 04:01PM
Nov 24, 2021 08:55AM Leronlimab (350 mg) Weekly Use for 14 Weeks in Open Label Arm of NASH Trial Produces Fibrosis Reduction as High as 93 msec Amongst First 15 Patients with Average Reduction of 24 msec
Nov 19, 2021 08:00AM
Nov 16, 2021 04:00PM
Nov 16, 2021 02:00PM
Nov 16, 2021 06:00AM
Nov 8, 2021 06:00AM
Nov 3, 2021 06:00AM
Nov 3, 2021 06:00AM CytoDyn Announces Cancer Update: 12-month Analysis of 28 mTNBC Patients Receiving Leronlimab Suggests an Increase of 3600% in 12-month OS in 75% of Patients with a Lower Level of Circulating Cells Aft
Oct 28, 2021 11:08AM
Oct 28, 2021 12:41AM
Oct 25, 2021 06:00AM
Oct 21, 2021 06:00AM
Oct 20, 2021 04:27PM
Oct 18, 2021 07:00AM
Oct 14, 2021 11:38AM Group of CytoDyn Stockholders Comments on Delaware Court Decision
Oct 14, 2021 07:00AM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All